Work

Hypoxia-upregulated microRNA-630 targets Dicer, leading to increased tumor progression

Year: 2016

Type: article

Source: Oncogene

DOI: 10.1038/onc.2015.492

Authors: R Rupaimoole, C Ivan, D Yang, K M Gharpure, S Y Wu, C V Pecot, R A Previs, A S Nagaraja, G N Armaiz-Pena, M McGuire, S Pradeep, L S Mangala, C Rodriguez-Aguayo, L Huang, M Bar-Eli, W Zhang, G Lopez-Berestein, G A Calin, A K Sood

Institutions: The University of Texas MD Anderson Cancer Center, University of Pittsburgh, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: MicroRNA in disease regulation

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences, National Center for Advancing Translational Sciences

Awards: G111615301, G2246080663, Texas Center for Cancer Nanomedicine, G281858550, G2851467072, Ovarian Cancer: Mechanisms of Neuroendocrine Regulation, G5393134058, Novel extra cellular RNA-based combinatorial RNA inhibition therapy, G6332391933, G6344965762, G6703021058, Nanovectors for Characterization and Destruction of Breast Tumor Vasculature, G840739938, The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer, Cancer Center Support Grant

OpenAlex ID: W2220171776

FWCI: 5.336

Cites: 31

Cited by: 96

Related to: 10